Indivior Pharmaceuticals annual gross profit
2021
2022
2023
2024
2025
Indivior Pharmaceuticals Gross Profit Growth & History (INDV)
Indivior Pharmaceuticals's gross profit was $994.0M for fiscal 2025.
View full Indivior Pharmaceuticals company overviewIndivior Pharmaceuticals annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $994.0M | $37.0M | +3.87% |
| 2024 | 2024-12-31 | $957.0M | $38.0M | +4.13% |
| 2023 | 2023-12-31 | $919.0M | $170.0M | +22.70% |
| 2022 | 2022-12-31 | $749.0M | $85.0M | +12.80% |
| 2021 | 2021-12-31 | $664.0M | — | — |
Indivior Pharmaceuticals quarterly gross profit
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $294.0M | $44.0M | +17.60% |
| Q1 2026 | 2026-03-31 | $277.0M | $56.0M | +25.34% |
| Q4 2025 | 2025-12-31 | $293.0M | $43.0M | +17.20% |
| Q3 2025 | 2025-09-30 | $230.0M | −$11.0M | −4.56% |
| Q2 2025 | 2025-06-30 | $250.0M | $30.0M | +13.64% |
| Q1 2025 | 2025-03-31 | $221.0M | −$25.0M | −10.16% |
| Q4 2024 | 2024-12-31 | $250.0M | — | — |
| Q3 2024 | 2024-09-30 | $241.0M | — | — |
| Q2 2024 | 2024-06-30 | $220.0M | — | — |
| Q1 2024 | 2024-03-31 | $246.0M | — | — |
Indivior Pharmaceuticals gross profit trends
Between the periods ended 2021-12-31 and 2025-12-31, Indivior Pharmaceuticals's gross profit increased from $664.0M to $994.0M, a change of $330.0M. The latest reported quarter, Q2 2026, shows $294.0M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Indivior Pharmaceuticals source filings ↗